Eyenovia

EYENOVIA INC

Eyenovia Inc is a clinical-stage ophthalmic company developing a pipeline of therapeutics based on its proprietary array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Optejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance, and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies that target new indications or new combinations.

Petróleo

Equities

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

APVO

BMEA

EYEN

GHLD

PSTV

RYDE

Crude Oil Moves Higher; US Weekly Jobless Claims Decline

Tallinn,,Estonia,-,August,4th,2023,-,Screen,With,Stock

Earnings

CERO

PTLE

Dow Surges 150 Points; Korn Ferry Earnings Top Views

Display,Of,Stock,Market,Quotes

Pre-Market Outlook

Movers

ACXP

CBIO

GOVX

GURE

HSDT

LDTC

LIMN

PHGE

SAFX

VNCE

XAIR

Why Beyond Air Shares Are Trading Lower By Over 23%; Here Are 20 Stocks Moving Premarket

Eyenovia Inc

Press Releases

Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements

Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq

General

Eyenovia Provides Development Update on Optejet User Filled Device (UFD)

Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results

Peraso Inc. (NASDAQ: PRSO): "The Convergence of Technical Momentum and Military Innovation" – More Stocks Inside

MAG 8 Momentum: NIVF, TRAW, KPRX, PNPN.V Lead $3 Undercard Surge – More Stocks Inside!

Innovations in Imaging, such as AI-Enhanced Retinal & Fundus Camera Systems are Booming Along with Revenue Opportunities

Eyenovia Announces $50 Million Investment to Launch a Hyperliquid (HYPE token) Cryptocurrency Treasury Reserve Strategy

Eyenovia Announces Appointment of a Strategic Advisor for Digital Asset Treasury Strategy and Amendment of Debt Agreement with Avenue Capital Group

Fintech

Chardan Expands into Digital Assets by Advising Strategic Crypto-Backed Financings

AVAI

BLCO

EDBL

KIDZ

KPRX

LGHL

NIVF

OTLK

PNPNF

PRSO

QIPT

SNYR

TRAW

TSXV:PNPN

VVPR

Addex Therapeutics Ltd - American Depositary Shares

Addex Therapeutics

Aspire Biopharma Holdings, Inc. - Common Stock

Aspire Biopharma Hldgs

Athira Pharma

Aytu BioPharma

Biofrontera

Cognition Therapeutics, Inc. - Common Stock

Cognition Therapeutics

Cocrystal Pharma

Citius Pharmaceuticals, Inc. - Common Stock

Citius Pharmaceuticals

Gelteq

IM Cannabis

Incannex Healthcare

Kiora Pharmaceuticals, Inc. - Common Stock

Kiora Pharmaceuticals

Lexaria Bioscience

Lipocine

Lyra Therapeutics

NLS Pharmaceutics

Purple Biotech Ltd. - American Depositary Shares

Purple Biotech

ProPhase Labs

Rani Therapeutics Holdings, Inc. - Class A Common Stock

Rani Therapeutics Hldgs

SenesTech

Talphera

Traws Pharma

TherapeuticsMD

VYNE Therapeutics

cbdMD

HC Wainwright & Co.

Comments

Eyenovia

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell